Piramal Finance has partnered with ICICI Bank to improve credit accessibility for middle and low-income borrowers, especially in rural and semi-urban regions, focusing on Home Loans and Loan Against Property. This collaboration strengthens Piramal Finance’s position in India’s semi-urban regions, reinforcing its commitment for providing easy and affordable credit solutions to the borrowers.
Through this partnership, the company combines its innovative ‘High Tech + High Touch’ approach with the financial and banking expertise of ICICI Bank. Additionally, the company’s strong presence across 510+ branches in 13,000 pin codes, serving 4.5 million customers in 26 states, will further bolster outreach and accessibility.
This partnership aims to expand access to mortgage credit for MSMEs, home loan seekers through competitive rates and tailored solutions. By focusing on Tier 2 and Tier 3 cities, it will provide affordable credit and benefit borrowers across key sectors, and contribute to economic growth. The collaboration aligns with the broader goal of strengthening India’s credit ecosystem and ensuring greater financial security to individuals and businesses.
Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1795.50 |
Dr. Reddys Lab | 1203.05 |
Cipla | 1549.00 |
Lupin | 2141.40 |
Zydus Lifesciences | 880.10 |
View more.. |